Last reviewed · How we verify

Antipyrine-benzocaine otic solution

Global United Pharmaceutical Corporation · Phase 2 active Small molecule

Antipyrine-benzocaine otic solution is a Local anesthetic Small molecule drug developed by Global United Pharmaceutical Corporation. It is currently in Phase 2 development for Ear pain relief, Otitis externa treatment.

Antipyrine-benzocaine otic solution works by providing local anesthetic and analgesic effects to the ear.

Antipyrine-benzocaine otic solution works by providing local anesthetic and analgesic effects to the ear. Used for Ear pain relief, Otitis externa treatment.

At a glance

Generic nameAntipyrine-benzocaine otic solution
SponsorGlobal United Pharmaceutical Corporation
Drug classLocal anesthetic
ModalitySmall molecule
Therapeutic areaOphthalmology
PhasePhase 2

Mechanism of action

The combination of antipyrine and benzocaine in this otic solution helps to reduce pain and inflammation in the ear, while also providing a numbing effect to make procedures less uncomfortable.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Antipyrine-benzocaine otic solution

What is Antipyrine-benzocaine otic solution?

Antipyrine-benzocaine otic solution is a Local anesthetic drug developed by Global United Pharmaceutical Corporation, indicated for Ear pain relief, Otitis externa treatment.

How does Antipyrine-benzocaine otic solution work?

Antipyrine-benzocaine otic solution works by providing local anesthetic and analgesic effects to the ear.

What is Antipyrine-benzocaine otic solution used for?

Antipyrine-benzocaine otic solution is indicated for Ear pain relief, Otitis externa treatment.

Who makes Antipyrine-benzocaine otic solution?

Antipyrine-benzocaine otic solution is developed by Global United Pharmaceutical Corporation (see full Global United Pharmaceutical Corporation pipeline at /company/global-united-pharmaceutical-corporation).

What drug class is Antipyrine-benzocaine otic solution in?

Antipyrine-benzocaine otic solution belongs to the Local anesthetic class. See all Local anesthetic drugs at /class/local-anesthetic.

What development phase is Antipyrine-benzocaine otic solution in?

Antipyrine-benzocaine otic solution is in Phase 2.

What are the side effects of Antipyrine-benzocaine otic solution?

Common side effects of Antipyrine-benzocaine otic solution include Ear discomfort, Hearing loss.

Related